Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Restructuring Costs (2022 - 2023)

Bioregenx has reported Restructuring Costs over the past 2 years, most recently at $6193.0 for Q4 2023.

  • For Q4 2023, Restructuring Costs fell 8.43% year-over-year to $6193.0; the TTM value through Dec 2023 reached $18254.0, down 33.97%, while the annual FY2023 figure was $18254.0, 33.97% down from the prior year.
  • Restructuring Costs for Q4 2023 was $6193.0 at Bioregenx, up from $1003.0 in the prior quarter.
  • Over five years, Restructuring Costs peaked at $9168.0 in Q1 2023 and troughed at $1003.0 in Q3 2023.